We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · December 04, 2020

Empagliflozin in Nondiabetic Patients With HFrEF

JACC: Journal of the American College of Cardiology


Additional Info

Disclosure statements are available on the authors' profiles:

JACC: Journal of the American College of Cardiology
Randomized Trial of Empagliflozin in Non-Diabetic Patients With Heart Failure and Reduced Ejection Fraction
J Am Coll Cardiol 2020 Nov 13;[EPub Ahead of Print], CG Santos-Gallego, AP Vargas-Delgado, JA Requena, et al

Further Reading